These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 36902493)

  • 1. Molecular Pathology, Diagnostics and Therapeutics: A Story of Success in 2022.
    Bustin SA
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrating molecular diagnostics into histopathology training: the Belfast model.
    Flynn C; James J; Maxwell P; McQuaid S; Ervine A; Catherwood M; Loughrey MB; McGibben D; Somerville J; McManus DT; Gray M; Herron B; Salto-Tellez M
    J Clin Pathol; 2014 Jul; 67(7):632-6. PubMed ID: 24493649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathology curriculum for medical laboratory scientists: A report of the association for molecular pathology training and education committee.
    Taylor S; Bennett KM; Deignan JL; Hendrix EC; Orton SM; Verma S; Schutzbank TE
    J Mol Diagn; 2014 May; 16(3):288-96. PubMed ID: 24745724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular diagnostics: Molecular Med Tri-Con 2013.
    Klein RD
    Expert Rev Mol Diagn; 2013 Jul; 13(6):527-8. PubMed ID: 23895123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular Pathology, Diagnostics, and Therapeutics of Nephropathy.
    Kronbichler A; Tesar V
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Companion diagnostics: a regulatory perspective from the last 5 years of molecular companion diagnostic approvals.
    Roscoe DM; Hu YF; Philip R
    Expert Rev Mol Diagn; 2015; 15(7):869-80. PubMed ID: 26109316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single molecular weight discrete PEG compounds: emerging roles in molecular diagnostics, imaging and therapeutics.
    Povoski SP; Davis PD; Colcher D; Martin EW
    Expert Rev Mol Diagn; 2013 May; 13(4):315-9. PubMed ID: 23638813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Certification in molecular pathology in the United States: an update from the Association for Molecular Pathology Training and Education Committee.
    Mackinnon AC; Wang YL; Sahota A; Yeung CC; Weck KE
    J Mol Diagn; 2012 Nov; 14(6):541-9. PubMed ID: 22925695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized cancer medicine and the future of pathology.
    Moch H; Blank PR; Dietel M; Elmberger G; Kerr KM; Palacios J; Penault-Llorca F; Rossi G; Szucs TD
    Virchows Arch; 2012 Jan; 460(1):3-8. PubMed ID: 22143935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Building a 'Repository of Science': The importance of integrating biobanks within molecular pathology programmes.
    Lewis C; McQuaid S; Hamilton PW; Salto-Tellez M; McArt D; James JA
    Eur J Cancer; 2016 Nov; 67():191-199. PubMed ID: 27677055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular pathology as the driving force for personalized oncology.
    Oktay MH; Hui P
    Expert Rev Mol Diagn; 2012 Nov; 12(8):811-3. PubMed ID: 23249199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Personalized oncology: recent advances and future challenges.
    Kalia M
    Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Consultant's intermediary role in the regulation of molecular diagnostics in the US.
    Holloway K; Miller FA
    Soc Sci Med; 2022 Jul; 304():112929. PubMed ID: 32201019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Forces driving change in medical diagnostics.
    Panagiotou N
    Clin Chim Acta; 2013 Jan; 415():31-4. PubMed ID: 22982817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular diagnostics and personalised medicine in wound care: assessment of outcomes.
    Dowd SE; Wolcott RD; Kennedy J; Jones C; Cox SB
    J Wound Care; 2011 May; 20(5):232, 234-9. PubMed ID: 21647068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Pathology in the Era of Personalized (Precision) Medicine: A Brief Review.
    Vranic S; Gatalica Z
    Acta Med Acad; 2021 Apr; 50(1):47-57. PubMed ID: 34075763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanotechnology-based approaches for the development of diagnostics, therapeutics, and vaccines.
    Srinivasan A; Rastogi A; Ayyavoo V; Srivastava S
    Monoclon Antib Immunodiagn Immunother; 2014 Jun; 33(3):186-91. PubMed ID: 24937250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expanding the Scope of The Journal of Molecular Diagnostics to the Informatics Subdivision of the Association for Molecular Pathology.
    Carter AB; Zehnbauer B
    J Mol Diagn; 2019 Jul; 21(4):539-541. PubMed ID: 31230765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contemporary Historical Development and Analysis of In Vitro Diagnostics(IVD)].
    Xing J; Zhang X
    Zhongguo Yi Liao Qi Xie Za Zhi; 2017 Nov; 41(6):428-431. PubMed ID: 29862703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current Topics in Molecular Diagnostics and Precision Medicine.
    Tsongalis GJ
    Clin Lab Med; 2022 Dec; 42(4):xi-xii. PubMed ID: 36368791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.